Anavex Life Sciences Corp (NASDAQ:AVXL)
| 6.35 Delayed Data As of 3:59pm ET |  +0.09 / +1.44%Today’s Change | 6.10 Today|||52-Week Range 15.24 | -31.43% Year-to-Date |
Latest AVXL News | Press Releases
No recent news for Anavex Life Sciences Corp.
Today’s Trading
| Previous close | 6.26 |
| Today’s open | 6.19 |
| Day’s range | 6.18 - 6.39 |
| Volume | 33,492 |
| Average volume (3 months) | 905,724 |
| Market cap | $538.4M |
Data as of 3:59pm ET, 10/04/2023
Growth & Valuation
| Earnings growth (last year) | -14.86% |
| Earnings growth (this year) | -12.50% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Taihe Group Inc | 0.00 | 0.00% |
| CBUSCibus Inc | +0.78 | +4.16% |
| AMRNAmarin Corporation P... | -0.03 | -3.61% |
| --Oxford Biomedica PLC | 0.00 | 0.00% |
Data as of 3:59pm ET, 10/04/2023
Financials
| Next reporting date | December 12, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$48.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
